Gianluca Franceschini

ORCID: 0000-0002-2950-3395
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Treatment and Pharmacology
  • Cancer and Skin Lesions
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Breast Cancer Therapies
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • MRI in cancer diagnosis
  • HER2/EGFR in Cancer Research
  • Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • AI in cancer detection
  • Global Cancer Incidence and Screening
  • Marine and fisheries research
  • Lymphatic System and Diseases
  • Cancer Risks and Factors
  • Reconstructive Facial Surgery Techniques
  • Marine Bivalve and Aquaculture Studies
  • Cancer Cells and Metastasis
  • Body Image and Dysmorphia Studies
  • Estrogen and related hormone effects
  • Cancer Immunotherapy and Biomarkers

Agostino Gemelli University Polyclinic
2016-2025

Università Cattolica del Sacro Cuore
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2019-2025

Istituto Superiore per la Protezione e la Ricerca Ambientale
2015-2024

Food and Agriculture Organization of the United Nations
2004-2024

Azienda Sanitaria Locale Alessandria
2024

University of Florence
2024

Ministero della Salute
2023

Weatherford College
2022

Ospedale Santa Chiara
2020

Reliable global data on forest degradation and disturbances due to fire, insect pests, diseases severe weather are important understand ecosystem health condition, safeguard production of goods services avoid negative impacts human livelihoods. This paper presents a analysis area affected by significant pest outbreaks, reported countries as part the Global Forest Resources Assessment 2015. Between 2003 2012, approximately 67 million hectares (1.7%) land burned annually, mostly in tropical...

10.1016/j.foreco.2015.06.010 article EN cc-by-nc-nd Forest Ecology and Management 2015-09-01

Hormone receptor-positive/HER2-negative breast cancer (BC) is the most common subtype of BC and typically occurs as an early, operable disease. In patients receiving neoadjuvant chemotherapy (NACT), pathological complete response (pCR) rare multiple efforts have been made to predict disease recurrence. We developed a framework pCR using clinicopathological characteristics widely available at diagnosis. The machine learning (ML) models were trained (n = 463), evaluated in internal validation...

10.1038/s41523-025-00727-w article EN cc-by-nc-nd npj Breast Cancer 2025-02-05

Background: Implant-based breast reconstruction (IBBR) following conservative mastectomy is the most common approach for women undergoing cancer surgery. The aim of this study was to compare oncological outcomes combined with prepectoral IBBR subpectoral technique. Methods: clinical and demographic data consecutive patients who underwent either or between January 2018 December 2023 were retrospectively analyzed. primary outcome impact on local recurrence-free survival (LRFS). Secondary...

10.3390/cancers17060925 article EN Cancers 2025-03-08

The purpose of this study was to determine the reliability sonographic American College Radiology Breast Imaging Reporting And Data System (BI-RADS) classification in differentiating benign from malignant breast masses.One hundred seventy-eight masses studied by sonography with a known diagnosis were reviewed. All lesions classified according BI-RADS lexicon. Pathologic results compared features. Sensitivity, specificity, accuracy, and positive predictive value (PPV) negative (NPV) for...

10.7863/jum.2006.25.5.649 article EN Journal of Ultrasound in Medicine 2006-05-01

Background: The aim of this study was to compare outcomes immediate prosthetic breast reconstruction (IPBR) using traditional submuscular (SM) positioning implants versus prepectoral (PP) micropolyurethane-foam-coated (microthane) without further coverage. Methods: We retrospectively reviewed the medical records cancer patients treated by nipple-sparing mastectomy (NSM) and IPBR in our institution during two-year period from January 2018 December 2019. Patients were divided into two groups...

10.3390/jpm11020153 article EN Journal of Personalized Medicine 2021-02-22

Mesenchymal tumors of the breast represent a rare and diverse group neoplasms, accounting for 0.5% all tumors. These originate from mesenchymal tissues encompass variety histological subtypes. Malignant are particularly aggressive, characterized by high propensity local recurrence an overall poor prognosis. The rarity these cases has hindered development robust clinical studies, resulting in lack standardized diagnostic treatment guidelines considerable variability management. This review...

10.20944/preprints202501.2276.v1 preprint EN 2025-01-30
Coming Soon ...